- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: Expanded Access
Total 3662 results
-
PfizerNo longer available
-
Eisai Inc.Approved for marketing
-
ERYtech PharmaNo longer available
-
Novartis PharmaceuticalsCompleted
-
Boehringer IngelheimApproved for marketingCarcinoma, Non-Small-Cell LungKorea, Republic of
-
Vertex Pharmaceuticals IncorporatedApproved for marketing
-
University of Sao Paulo General HospitalCompletedPrimary Biliary Cirrhosis | Ursodeoxycholic AcidBrazil
-
Clovis Oncology, Inc.No longer available
-
Astellas Pharma Global Development, Inc.No longer availableAcute Myeloid Leukemia (AML) | FMS-like Tyrosine Kinase-3 (FLT3) MutationsAustralia, Italy, United Kingdom
-
PfizerNo longer availableGaucher DiseaseUnited States, Israel
-
Cyclo Therapeutics, Inc.Kerwin Research Center, LLCNo longer availableLate Onset Alzheimer Disease
-
Rigel PharmaceuticalsNo longer availableImmune Thrombocytopenic Purpura
-
Agios Pharmaceuticals, Inc.Approved for marketingAcute Myeloid Leukemia | Relapsed Pediatric AML | Relapsed Adult AML
-
Novartis PharmaceuticalsCompletedCushing's DiseaseUnited States, Germany, Korea, Republic of, Spain, Thailand, Lebanon, Romania, Greece, Brazil, Russian Federation, Czechia
-
Celldex TherapeuticsNo longer availableMetastatic gpNMB Expressing Triple Negative Breast Cancer
-
AstraZenecaNo longer availablePSR Ovarian Cancer With a BRCA MutationJapan
-
Genentech, Inc.Approved for marketingHemophilia AUnited States
-
CytoDyn, Inc.Amarex Clinical ResearchNo longer available
-
La Jolla Pharmaceutical CompanyApproved for marketingSepsis | Vasodilatory Shock | Distributive Shock | High Output Shock | Catecholamine Resistant Hypotension (CRH)
-
PTC TherapeuticsParexel; Dohmen Life Science ServicesApproved for marketingDuchenne Muscular DystrophyUnited States
-
Ariad PharmaceuticalsApproved for marketingChronic Myeloid Leukemia (CML) | Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)United States
-
Ariad PharmaceuticalsNo longer availableCarcinoma | Lung Cancer | Non-small Cell Lung Cancer | Advanced MalignanciesUnited States
-
University of MinnesotaNo longer availableX-linked AdrenoleukodystrophyUnited States
-
Center Trials & TreatmentNo longer availableGlioblastoma Multiforme | Melanoma (Skin) | Melanoma Recurrent | Glioma of Brain | Glioblastoma by Gene Expression ProfileHong Kong, Belarus, Tajikistan, Uzbekistan
-
Sage TherapeuticsNo longer availableSuper-Refractory Status Epilepticus
-
Eli Lilly and CompanyApproved for marketingMetastatic Breast CancerUnited States
-
AstraZenecaParexelApproved for marketing
-
Celldex TherapeuticsNo longer available
-
Genentech, Inc.No longer availableMultiple SclerosisUnited States
-
Jean M. Tersak, M.D.PfizerNo longer availableInflammatory Myofibroblastic Tumour
-
University of FloridaNo longer availableMitochondrial Enzyme DeficienciesUnited States
-
PfizerNo longer availableNeoplasms | Carcinoma, Non-Small-Cell LungJapan
-
Providence Health & ServicesPatient-Centered Outcomes Research Institute; Oregon Health and Science University and other collaboratorsUnknown
-
Cubist Pharmaceuticals LLCTerminatedGram-Positive Bacterial Infections
-
Boehringer IngelheimApproved for marketingIdiopathic Pulmonary FibrosisUnited States
-
AmgenMultiple Myeloma Research FoundationApproved for marketing
-
ACADIA Pharmaceuticals Inc.Approved for marketingParkinson's Disease Psychosis
-
Tesaro, Inc.Approved for marketingRecurrent Ovarian Cancer
-
Genentech, Inc.CompletedChronic Lymphocytic LeukemiaUnited States
-
ViiV HealthcareGlaxoSmithKlineNo longer availableInfection, Human Immunodeficiency VirusBelgium, Russian Federation, Italy, South Africa, Argentina, Switzerland, Poland
-
Genentech, Inc.No longer available
-
Astellas Pharma Global Development, Inc.Medivation, Inc.Approved for marketingMetastatic Castration-Resistant Prostate Cancer
-
Bristol-Myers SquibbNo longer availableMalignant MelanomaUnited States, Canada
-
Hoffmann-La RocheCompletedHepatitis B, ChronicNew Zealand
-
Washington University School of MedicineApproved for marketingCancer of the ProstateUnited States
-
GlaxoSmithKlineCompleted
-
Boehringer IngelheimApproved for marketing
-
Boehringer IngelheimApproved for marketingHIV InfectionsUnited States